PFE News

Recent headlines mentioning PFE, newest first.

PFE bullish

Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?

insidermonkey.com·Oct 16, 2026·Pfizer Inc. (NYSE:PFE) trades at a considerable discount to AbbVie Inc. (NYSE:ABBV), despite both companies reporting growth in important parts of their pharmac...
PFE bullish

Lisata Therapeutics Appoints Jeff Farrow to Board of Directors

manilatimes.net·Oct 14, 2026·Veteran biopharma CFO brings more than 15 years of public-company financial leadership across development, approval and commercial launch; joins Audit Committee...
PFE neutral

Pfizer (PFE) Trades Below 10x Earnings. Why Does Johnson & Johnson (JNJ) Command More Than Twice the Multiple?

insidermonkey.com·Oct 7, 2026·Pfizer Inc. (NYSE:PFE) looks cheap based on its forward P/E, but its earnings outlook helps explain the discount. But unlike Johnson & Johnson or Eli Lilly, Pfi...
PFE neutral

Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia

manilatimes.net·Oct 7, 2026·First patient enrolled in cohort combining bexobrutideg with venetoclax Initial cohort to focus on relapsed/refractory CLL, with potential expansion to first-l...
PFE neutral

Is Pfizer (PFE) a Good or Bad Investment at Today’s Price?

insidermonkey.com·Oct 6, 2026·Pfizer Inc. (NYSE:PFE) was trading at around $27 on October 5, down 1.35% on the day and up 5.18% over twelve months. The shares yield 6.19%. The company paid ...
PFE neutral

Pfizer Keeps Its Dividend Steady With a Yield Above 6%

gurufocus.com·Oct 6, 2026·Pfizer Inc. (PFE, Financials) is retaining its quarterly dividend at 43 cents a share, sustaining one of the stock's key attractions for income investors. Its ...
PFE bullish

Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

manilatimes.net·Oct 5, 2026·Two-year extension builds on productive relationship established in 2019 Nurix continues to retain co-development and 50/50 profit sharing options on up to two...
PFE neutral

Pfizer (PFE) Reports Positive Phase 3 Trial Results for LITFULO in Vitiligo Treatment

gurufocus.com·Oct 2, 2026·On October 02, 2026, Pfizer Inc (NYSE: PFE) announced encouraging results from its pivotal Phase 3 studies evaluating LITFULO, a daily oral therapy for vitiligo...
PFE neutral

Pfizer's Alopecia Drug Litfulo Shows Promising Phase 3 Results, Boosting Confidence in Dividend Stock (PFE)

gurufocus.com·Oct 2, 2026·On October 02, 2026, Pfizer Inc (NYSE: PFE) announced that its alopecia treatment, Litfulo (ritlecitinib), demonstrated significant efficacy in two phase 3 clin...
PFE neutral

CMS Finalizes GLOBE Model Impacting Pfizer (PFE) with Dividend Sustainability in Focus

gurufocus.com·Oct 2, 2026·On October 02, 2026, the Centers for Medicare & Medicaid Services (CMS) finalized its GLOBE Model, a new initiative aimed at reducing costs for certain drugs ad...
PFE bearish

Florida Attorney General Sues Pfizer (PFE) Over COVID-19 Vaccine Marketing Claims

gurufocus.com·Oct 1, 2026·On October 01, 2026, Florida Attorney General James Uthmeier filed a lawsuit against Pfizer Inc (NYSE: PFE) and its CEO Albert Bourla, alleging misleading marke...
PFE neutral

Pfizer (PFE) Reports Positive Phase 2 Results for Tilrekimig in Atopic Dermatitis

gurufocus.com·Oct 1, 2026·On October 01, 2026, Pfizer Inc (NYSE: PFE) announced encouraging outcomes from its Phase 2 clinical trial of tilrekimig, an experimental therapy targeting atop...
PFE neutral

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

manilatimes.net·Sep 29, 2026·Milestone reflects continued progress in collaboration to develop a novel class of degrader antibody conjugates, or DACs BRISBANE, Calif., Sept. 29, 2026 (GLOB...
PFE neutral

Pfizer: Growth Portfolio And Cost Cuts Support A Buy Through The LOE Trough (NYSE:PFE)

seekingalpha.com·Sep 29, 2026·Pfizer ( PFE ) is a good medium- to long-term investment despite near-term challenges from COVID revenue normalization and looming patent expiry over the coming...
PFE neutral

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

zacks.com·Sep 28, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
PFE neutral

JPMorgan Lowers Haleon (HLN) Price Target Amid Dividend Sustainability Concerns

gurufocus.com·Sep 28, 2026·On September 28, 2026, JPMorgan revised its price target for Haleon PLC (NYSE: HLN) downward to 295 GBp from 315 GBp, maintaining an Underweight rating and plac...
PFE neutral

Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own?

insidermonkey.com·Sep 27, 2026·Pfizer Inc. (NYSE:PFE) and Gilead Sciences, Inc. (NASDAQ:GILD) present investors with two very different forms of concentration risk. Pfizer needs newer medicin...
PFE bullish

Pfizer: The 10-Year Is At 5%, And I’m Still Buying This 6%+ Yield (NYSE:PFE)

seekingalpha.com·Sep 21, 2026·I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an easy retirement by creating a portfolio which focuses ...
PFE neutral

PFE Looks 4.5% Overvalued on GF Value™ as Dividend Sustainability Remains Key

gurufocus.com·Sep 21, 2026·On September 21, 2026, Pfizer Inc (NYSE: PFE) announced a new “most favored nation” contract with the US Department of Health and Human Services (HHS) to sh...
PFE neutral

Pfizer Says Its Biggest Headwinds Are Finally Easing. Does That Change the Story for This Ultra-High-Yield Dividend Stock?

finance.yahoo.com·Sep 20, 2026·The past few years have been challenging for Pfizer (NYSE: PFE). The company has faced macroeconomic problems, significantly lower sales from its coronavirus po...
PFE bullish

PFE Looks 4.1% Overvalued on GF Value™ Amid Strong Dividend Profile

gurufocus.com·Sep 15, 2026·On September 15, 2026, the U.S. FDA announced the launch of the Expedited Investigational New Drug (IND) Pilot Program aimed at accelerating the timeline for fi...
PFE neutral

Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat

finance.yahoo.com·Sep 15, 2026·Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Applicati...
PFE neutral

Pfizer Inc. (PFE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

seekingalpha.com·Sep 14, 2026·Presentation Well, I'm very pleased to be hosting Pfizer this morning at our conference. Thanks so much to Albert Bourla, who's the company's CEO and Chairman....
PFE bullish

Yield Hunters Are Swarming This 6.3%-Dividend Stock—And Big-League Hedge Funds are Quietly Buying the Dip

finance.yahoo.com·Aug 20, 2026·Quick Read Hedge funds are quietly accumulating Pfizer shares. Moderna's 177% single-day cancer vaccine surge spotlights Pfizer's underrated oncology pipeline...
PFE bullish

Indian startup aims to compete with OpenAI in crowded voice arena

thehindubusinessline.com·Aug 20, 2026·Bangalore-based startup has entered the crowded race to build artificial voices that sound human, with an AI model that garners high scores versus systems from ...
PFE neutral

Zoetis Q2 Earnings Call Highlights

finance.yahoo.com·Aug 9, 2026·Global companion-animal revenue was $1.7 billion, down 6% in the quarter. U.S. companion-animal revenue declined 11% to $1 billion, while international companio...
PFE neutral

Pfizer Inc. (PFE) Q2 2026 Earnings Call Transcript

seekingalpha.com·Aug 4, 2026·Presentation Good day, everyone, and welcome to Pfizer's Second Quarter 2026 Earnings Conference Call. Today's call is being recorded. At this time, I would li...
PFE bullish

US stocks: Dow, S&P 500 close at record highs as AI earnings impress, oil prices tumble

economictimes.indiatimes.com·Aug 4, 2026·Live Events as a Reliable and Trusted News Source Addas a Reliable and Trusted News Source Add Now! (You can now subscribe to our (You can now subscribe to...
PFE neutral

NYSE Content Update: ADI to Make NYSE Trading Debut After Spin-Off

manilatimes.net·Aug 4, 2026·NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today'...
PFE neutral

AI Agents and Firms Dominate This Week’s Funding Announcements

crowdfundinsider.com·Aug 3, 2026·Freehand lands $75M for AI agents Freehand’s AI agents manage supply-chain spend for Fortune 500 enterprises. The round was co-led by Battery Ventures and Ne...
PFE neutral

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

manilatimes.net·Aug 2, 2026·Appointments put dedicated leadership behind two separate priorities: building Ascentage Pharma’s own commercial organization in the United States, and expand...
PFE neutral

The Latest Thoughts From American Technology Companies On AI (2026 Q2) : The Good Investors %

thegoodinvestors.sg·Aug 2, 2026·The way I see it, artificial intelligence (or AI), really leapt into the zeitgeist in late-2022 or early-2023 with the public introduction of DALL-E2 and ChatGP...
PFE neutral

Pfizer: Still Mispriced By Mr. Market (Earnings Preview) (NYSE:PFE)

seekingalpha.com·Jul 31, 2026·Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall I...
PFE neutral

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

zacks.com·Jul 31, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
PFE bullish

Pfizer Inc. (PFE) vs. Eli Lilly and Company (LLY): The Growth vs. Value Play in Pharma

insidermonkey.com·Jul 30, 2026·Pfizer (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) offer unique divergent investment opportunities in the pharmaceutical industry. While one acts as a value...
PFE bullish

Boomers Are Buying 5 Quality High-Yield Stocks at Big Discounts Hand Over Fist

finance.yahoo.com·Jul 29, 2026·Since 1926, dividends have accounted for approximately 32% of the S&P 500's total return, while capital appreciation has accounted for 68%. Therefore, sustainab...
PFE neutral

3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st

finance.yahoo.com·Jul 28, 2026·Quick Read ABBV trades at a PEG of 0.43 with a beta of just 0.28, while Skyrizi and Rinvoq combined for $6.6 billion in Q1 revenue. ABBV's 164% five-year gain...
PFE bearish

NYC Halts Construction at 222 Broadway Office-to-Residence Tower

insurancejournal.com·Jul 28, 2026·New York City’s Department of Buildings issued a stop-work order at a Manhattan office tower that’s being converted into apartments weeks after authorities ...
PFE bullish

Pfizer Stock: The AI Hedge That Pays You To Stay Defensive (NYSE:PFE)

seekingalpha.com·Jul 11, 2026·I have been bullish for quite some time now on Pfizer ( PFE ). But my bullish take hasn't lived up to its expectations yet. Since my previous coverage , the pha...
PFE neutral

Why companies pay a premium for battle-tested CFOs—and Nike’s struggling turnaround shows the cost

fortune.com·Jul 10, 2026·Good morning. Proven public-company CFOs are scarce enough that companies increasingly offer pre-paid packages when recruiting them away from other organization...